Artikel dengan mandat akses publik - DOMENICO PRATICOPelajari lebih lanjut
KeseluruhanNIHAHAEuropean CommissionFWFNSFCNWOWellcomeSNSFUSEDVAHHMIHSFDFGAcademy of FinlandFCTVersus Arthritis, UKBBSRCBHFCancer Research UKMRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKNIHRParkinson's UKWorldwide Cancer Research, UKDoris Duke Charitable FoundationANRDHFMichael J Fox FoundationUK Research & Innovation
Tidak tersedia di mana pun: 10
Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
D Praticò
Trends in pharmacological sciences 29 (12), 609-615, 2008
Mandat: US National Institutes of Health
Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows
D Pratico
Annals of the New York Academy of Sciences 1147 (1), 70-78, 2008
Mandat: US National Institutes of Health
Biochemical markers in persons with preclinical familial Alzheimer disease
JM Ringman, SG Younkin, D Pratico, W Seltzer, GM Cole, DH Geschwind, ...
Neurology 71 (2), 85-92, 2008
Mandat: US National Institutes of Health
Autophagy dysfunction in Alzheimer’s disease: mechanistic insights and new therapeutic opportunities
A Di Meco, ME Curtis, E Lauretti, D Praticò
Biological psychiatry 87 (9), 797-807, 2020
Mandat: US National Institutes of Health
The neurobiology of isoprostanes and Alzheimer's disease
D Praticò
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2010
Mandat: US National Institutes of Health
Prostanoid and isoprostanoid pathways in atherogenesis
D Praticò
Atherosclerosis 201 (1), 8-16, 2008
Mandat: US National Institutes of Health
F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients
J Connolly, A Siderowf, CM Clark, D Mu, D Pratico
Cognitive and behavioral neurology 21 (2), 83-86, 2008
Mandat: US National Institutes of Health
Increased type IIA secretory phospholipase A2 expression contributes to oxidative stress in end-stage renal disease
M van der Giet, M Tölle, D Pratico, V Lufft, M Schuchardt, MP Hörl, ...
Journal of molecular medicine 88, 75-83, 2010
Mandat: German Research Foundation
PCSK9 in metabolism and diseases
A Ajoolabady, D Pratico, M Mazidi, IG Davies, GYH Lip, N Seidah, P Libby, ...
Metabolism, 156064, 2024
Mandat: European Commission, Agence Nationale de la Recherche
Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOE
V Garliyev, CA Lyssenko, JP Wiener, D Praticò, NN Lyssenko
Journal of Neuropathology & Experimental Neurology, nlae060, 2024
Mandat: Michael J Fox Foundation
Tersedia di suatu tempat: 97
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Mandat: Swiss National Science Foundation, US National Institutes of Health, US …
Glycogen synthase kinase-3 signaling in Alzheimer's disease
E Lauretti, O Dincer, D Praticò
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1867 (5), 118664, 2020
Mandat: US National Institutes of Health
Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer’s disease
P Jadiya, DW Kolmetzky, D Tomar, A Di Meco, AA Lombardi, JP Lambert, ...
Nature communications 10 (1), 3885, 2019
Mandat: US National Institutes of Health
N‐acetylcysteine targets 5 lipoxygenase‐derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following …
SS Karuppagounder, L Alin, Y Chen, D Brand, MW Bourassa, K Dietrich, ...
Annals of neurology 84 (6), 854-872, 2018
Mandat: US National Institutes of Health, Heart and Stroke Foundation of Canada
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
M Brys, E Pirraglia, K Rich, S Rolstad, L Mosconi, R Switalski, ...
Neurobiology of aging 30 (5), 682-690, 2009
Mandat: US National Institutes of Health
Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes
AR Collins, CJ Lyon, X Xia, JZ Liu, RK Tangirala, F Yin, R Boyadjian, ...
Circulation research 104 (6), e42-e54, 2009
Mandat: US National Institutes of Health
5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer’s disease
O Firuzi, J Zhuo, CM Chinnici, T Wisniewski, D Praticò
The FASEB journal: official publication of the Federation of American …, 2008
Mandat: US National Institutes of Health
Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?
JM Zhuo, H Wang, D Praticò
Trends in pharmacological sciences 32 (9), 562-571, 2011
Mandat: US National Institutes of Health
Targeting autophagy in ischemic stroke: from molecular mechanisms to clinical therapeutics
A Ajoolabady, S Wang, G Kroemer, JM Penninger, VN Uversky, D Pratico, ...
Pharmacology & therapeutics 225, 107848, 2021
Mandat: US National Institutes of Health, Austrian Science Fund, National Natural …
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder
N Pomara, D Bruno, AS Sarreal, RT Hernando, J Nierenberg, E Petkova, ...
American Journal of Psychiatry 169 (5), 523-530, 2012
Mandat: US National Institutes of Health
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer